Annual Report

Riding a wave of strong financial performance, Knowles Corp. prepares to outline its future in Medtech, Defense, and Industrial markets to investors.

Mobile game maker DarkIris pivots to an AI-first strategy, launching an R&D hub in Singapore to build a pan-entertainment AGI content platform.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

Beasley Broadcast Group reports a staggering $190M Q4 loss after a massive asset write-down, but a major debt cut and digital growth signal a fight for survival.

XPeng reports an 80% monthly sales jump but a yearly decline, while launching a major strategic expansion into Mexico and Latin America.

A one-time gain gave the micro-cap a profitable quarter, but rising costs and reliance on a single large asset raise questions about its long-term stability.

Interlink Electronics reports a wider Q4 loss but makes key moves in autonomous vehicle and robotic surgery sensors, signaling a major strategic pivot.

The Texas fuel supplier is preparing a Nasdaq/NYSE move, banking on high energy prices from the Iran War to bolster its financials for the ambitious jump.

Tencent Music posts record profits and a huge dividend, but a shrinking user base and a new policy to hide key metrics leave investors wary.

As Argan prepares its Q4 results, investors are watching if its record backlog and dual energy strategy can sustain its powerful year-end performance.

UiPath reports its first-ever annual profit and a new $500M buyback, but its strategic pivot to agentic AI faces scrutiny over slowing growth.

After a 39% stock crash, Lakeland Industries' former CFO is sued over allegedly misleading investors about the company's deteriorating financial health.

The biopharma firm beats 2025 guidance on strong specialty and generic sales, forecasting another year of growth fueled by new product launches.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

Following strong Q4 earnings, Datadog will detail its AI and cloud strategy at a major conference, with investors and tech leaders watching closely.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

Malaysian solar firm FGL faces delisting after a reverse stock split, meant to save its listing, backfired and wiped out its public share float.

Despite a reported net loss, the REIT saw a 162% jump in key operational funds and a 22% surge in its senior housing portfolio's income.

Auto parts giant LKQ Corporation explores a potential sale after 2025 profits fall, despite strong cash flow and a new restructuring plan.